TELISHA NEMEC: Open Payments
NPI 1306565577 · TYLER, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$762 in 39 payments from 4 companies in 2025. Trend: 2023 $1,164 · 2024 $428 · 2025 $762
Food & beverage: $762
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $349 |
| Madrigal Pharmaceuticals | 13 | $291 |
| GENZYME CORPORATION | 4 | $92 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $31 |
Products named: REZDIFFRA, RINVOQ, SKYRIZI, DUPIXENT, EOHILIA, CREON, GATTEX, LINZESS.
Industry payments across TX — which companies pay providers there.
